Gliolan blev anvendt i én hovedundersøgelse med 415 patienter, som havde ondartet gliom og skulle opereres i hjernen for at få fjernet svulsten.
Gliolan has been studied in one main study involving 415 patients with malignant glioma who were about to undergo brain surgery to remove the tumour.